Detailed Quote
5i Report
Rating
B+
Review of WSP Global Inc
OCT 10, 2023
- WSP is a widely diversified company that has proven its ability to successfully acquire and integrate businesses to further its market expansion and top-line growth. The company has a strong pipeline of opportunities in its Canadian markets and has
seen organic and inorganic growth We continue to like WSP as an industry-leading name, and one that has achieved good financial results for its shareholders. As such, we are maintaining its rating at ‘B+’.
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Would you prefer STN over WSP today?
Also would you prefer KXS over DSG?
Also would you prefer KXS over DSG?
Q: I have been very happy with my WSP investment now at 100% gain. Out of the 2 companies which one do expect to grow faster? And if I were to split my investment how much would you allocate for each?
-
AbbVie Inc. (ABBV)
-
Abbott Laboratories (ABT)
-
Danaher Corporation (DHR)
-
Eli Lilly and Company (LLY)
-
UnitedHealth Group Incorporated (DE) (UNH)
-
WSP Global Inc. (WSP)
-
TFI International Inc. (TFII)
-
Novo Nordisk A/S (NVO)
-
WELL Health Technologies Corp. (WELL)
-
Heico Corporation (HEI)
-
Boyd Group Services Inc. (BYD)
Q: hi, can I get your best CDN and US ideas in the industrials and healthcare sectors right now, for long term investment. cheers, chris
Insiders
Share Information
News and Media